View
218
Download
4
Embed Size (px)
Citation preview
What We Have Learned:What We Have Learned:
Pharmaceutical Wrap-Around Programs
Victor J. Strecher, PhD, MPHProfessor and DirectorCenter for Health Communications
ResearchSchool of Public HealthUniversity of Michigan
Founder and ChairmanHealthMedia, Inc.
72%
7%
1%
11%
8%
1%
4%
6%
12%
8%
12%
25%
0% 10% 20% 30% 40% 50% 60% 70% 80%
No medication/ No
therapy
No medication/ Brief
therapy
No medication/
Intensive therapy
Medication*/ No therapy
Medication*/ Brief
therapy
Medication*/ Intensive
therapy
% Quit
% Use
* OTC use=85%; prescription use=15% of medication use
Percent of quitters who use each cessation therapy and long-term quit rates among those who use the therapy.
Hughes JR. Motivating and helping smokers to stop smoking. Journal of General Internal Medicine 2003; 18:1053-1057
crossing the chasm
-AIMRE-
crossing the chasm
AdoptionReach
Efficacy Maintenance
Implementation
crossing the chasm
DataProduction
Measures
Prototypes
AnalysisValidit
y Operations
Tech support
Design
Regulatory
Reach Efficacy Adoption Implementation Maintenance(ROI?) (turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
Reach Efficacy Adoption Implementation Maintenance
Group counseling (ROI?) (turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
Reach Efficacy Adoption Implementation Maintenance
Untailored print
Group counseling (turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
(ROI?)
Reach Efficacy Adoption Implementation Maintenance
Untailored print
Group counseling
Clinician counseling
(turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
(ROI?)
Reach Efficacy Adoption Implementation Maintenance
Untailored print
Group counseling
Clinician counseling
Proactive telephonic
(turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
(ROI?)
Reach Efficacy Adoption Implementation Maintenance
Untailored print
Group counseling
Clinician counseling
Reactive telephonic
Proactive telephonic
(turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
(ROI?)
Reach Efficacy Adoption Implementation Maintenance
Untailored print
Group counseling
Tailored print
Clinician counseling
Reactive telephonic
Proactive telephonic
(turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
(ROI?)
Reach Efficacy Adoption Implementation Maintenance
Untailored print
IVR
Group counseling
Tailored print
Clinician counseling
Reactive telephonic
Proactive telephonic
(turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
(ROI?)
Reach Efficacy Adoption Implementation Maintenance
Untailored print
IVR Public web
Group counseling
Tailored print
Clinician counseling
Reactive telephonic
Proactive telephonic
(turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
(ROI?)
Reach Efficacy Adoption Implementation Maintenance
Untailored print
IVR Public web
Branded web
Group counseling
Tailored print
Clinician counseling
Reactive telephonic
Proactive telephonic
(ROI?) (turn-key?) (scalable?)
Estimated status of behavioral wrap-arounds to pharmacological smoking cessation products (RE-AIM criteria).
0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 2.6 2.8 2.80.4
NRT+Tailored web (n=3501; Strecher et al, 2005) 3 mo (10wk ca): 23% vs 18%
NRT+Tailored print (n=3683; Shiffman et al, 2001) 3 mo (10wk ca): 18% vs 11%
NRT+Tailored print (n=2424; Shiffman et al, 2000) 3 mo (10wk ca): 28% vs 18%
NRT+Telecounseling (n=330; Solomon et al, 2005) 6 mo (7 day pp): 38% vs 30%
NRT+Telecounseling (n=214; Solomon et al, 2000) 6 mo (7 day pp): 23% vs 19%
NRT+Telecounseling (n=380; Ockene et al, 1991) 6 mo (7 day pp): 18% vs 15%
NRT+Telecounseling (n=336; Lando et al, 1997) 6 mo (7 day pp): 25% vs 23%
NRT+Untailored print (n=522; Fortmann & Killen, 1995) 6 mo (7 day pp): 28% vs 26%
NRT+Untailored print (n=303; Lando et al, 1988) 6 mo
NRT+Video (n=424; Killen et al, 1997) 6 mo 7 day pp): 16% vs 25%
Comparison of behavior adjuncts to nicotine replacement therapy (odds ratios):
2.04 [1.49-2.81]
1.78 [1.28-2.48]
1.14 [0.69-1.87]
1.01 [0.66-1.54]
0.82 [0.47-1.44]
0.60 [0.36-0.99]
1.23 [0.68-2.22]
1.29 [0.66-2.50]
1.42 [0.90-2.24]
Behavioral adjunct
1.34 [1.13-1.58]
Outcome expectations
Efficacy expectations
BEHAVIORPERSON OUTCOME
Perceived competence
• It is difficult for me to find effective solutions to the problems that come my way. (reversed)
• Typically, my plans don't work out well. (reversed)
• I succeed in the projects I undertake.
• I am able to do things as well as most other people.
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
Shallow Tailoring Deep Tailoring
High Competence
Low Competence
Abstinence at 6 month follow-up by shallow versus deeply tailored self-efficacy messages, stratified by perceived competence. Test of shallow tailoring sub-group: OR=1.66 (95% CI=1.07-2.60) p<.05. Test of interaction: OR=1.70 (95% CI=0.92-3.15) p<.10. PRELIMINARY DATA
Efficacy Expectation Messages
6-m
onth
abst
inence
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
Shallow Tailoring Deep Tailoring
High Competence
Low Competence
Abstinence at 6 month follow-up by shallow versus deeply tailored outcome messages, stratified by perceived competence. Test of shallow tailoring sub-group: OR=1.87 (95% CI=1.19-2.97) p<.01. Test of interaction: OR=2.05 (95% CI=1.11-3.84) p<.05. PRELIMINARY DATA
Outcome Expectation Messages
6-m
onth
abst
inence
“The best way to predict the future is to invent it.”
Alan Kay
• Promote reach via media (e.g., inclusion in product advertising; periodically offering the program for free).
• Promote reach by creating stand-alone program that smokers pay for.
• Enhances perceived value.
• Increases ROI
• Improve the value of the program to the consumer through program enhancements.
Conclusions
Thank you
Victor J. Strecher, PhD, MPHProfessor and DirectorCenter for Health Communications
ResearchSchool of Public HealthUniversity of Michigan
Founder and ChairmanHealthMedia, Inc.